tradmap

NSPR Financials InspireMD, Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 29.3% per year over the past 5 years.
  • Operating margin has contracted, at -552.6% in the latest year.

Financial health

  • Total debt has grown slower than revenue (-43.7% vs 29.3% per year).
  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$49M -$20M $9M $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-553% -262% 30% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-327% 287% 900% 0% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$37M -$18M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $9M $19M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$35M $10M $56M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $9M -$49M 29.5% -552.6% -88.4% -70.3% -$37M $9M
2024 $7M -$32M 21.5% -478.0% -88.7% -68.4% -$23M $19M
2023 $6M -$20M 29.1% -340.7% -50.4% -41.8% -$17M $10M
2022 $5M -$18M 21.6% -361.9% -106.3% -75.0% -$16M $5M
2021 $4M -$15M 16.8% -327.4% -44.5% -37.6% -$14M $12M
2020 $2M -$11M 3.3% -417.7% -86.7% -59.3% -$9M $13M
2019 $4M -$10M 20.3% -263.8% -186.5% -101.6% -$10M $6M
2018 $4M -$7M 27.6% -211.4% -82.6% -58.9% -$8M $9M
2017 $3M -$8M 21.2% -298.2% -309.4% -138.2% -$8M $4M
2016 -$8M -209.2% -89.9% $8M
2015 -$16M 529.0% -273.8% $5M $3M
2014 -$25M 900.4% -219.0% $9M $6M
2013 -$29M -181.7% -141.0% -$11M $15M
2012 -$18M -326.7% -109.9% -$9M $10M
2011 -$15M -217.1% -140.1% -$6M $5M

Valuation over time

How the market has priced NSPR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 15.6 31.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is NSPR growing its revenue and profit?

Over the past 5 years, InspireMD, Inc.'s revenue has grown 29.3% per year. These are computed facts, not advice.

How much debt does NSPR have?

As of FY2025, InspireMD, Inc. reported — of total debt against $9M of cash.

What is NSPR's profit margin?

In FY2025, gross margin was 29.5%, operating margin -552.6%, and net margin -543.4%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.